Medicine and Dentistry
Rheumatoid Arthritis
100%
Patient
52%
Disease Modifying Antirheumatic Drug
31%
Systematic Review
31%
Therapeutic Procedure
26%
Randomized Controlled Trial
20%
Health Assessment Questionnaire
20%
Drug
19%
TNF Inhibitor
18%
Intensive Care
18%
Disease
17%
Spontaneous Remission
15%
Disability
14%
Observational Study
12%
Disease Activity Score
12%
Quality of Life
12%
Biological Product
12%
Rheumatology
11%
Health
11%
Quality Adjusted Life Year
10%
Salazosulfapyridine
10%
Amaurosis
9%
Diclofenac
9%
Biological Marker
9%
Arthritis
9%
Muscle Disease
9%
Disease-Modifying Antirheumatic Drug
8%
Health Care Cost
8%
General Practitioner
6%
Secondary Care
6%
Disease Activity
5%
Disease Duration
5%
Nursing and Health Professions
Patient
48%
Remission
24%
Quality of Life
18%
Tumor Necrosis Factor Inhibitor
18%
Clinical Practice
12%
Meta Analysis
10%
Quality Adjusted Life Year
10%
Systematic Review
9%
Clinical Effectiveness
9%
Cost Effectiveness Analysis
6%
General Practitioner
6%
Control
5%
